Mus musculus Gene: Cyld | |||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Summary | |||||||||||||||||||||||||||||||
InnateDB Gene | IDBG-179176.6 | ||||||||||||||||||||||||||||||
Last Modified | 2014-10-13 [Report errors or provide feedback] | ||||||||||||||||||||||||||||||
Gene Symbol | Cyld | ||||||||||||||||||||||||||||||
Gene Name | cylindromatosis (turban tumor syndrome) | ||||||||||||||||||||||||||||||
Synonyms | 2010013M14Rik; 2900009M21Rik; C130039D01Rik; CDMT; CYLD1; EAC; mKIAA0849 | ||||||||||||||||||||||||||||||
Species | Mus musculus | ||||||||||||||||||||||||||||||
Ensembl Gene | ENSMUSG00000036712 | ||||||||||||||||||||||||||||||
Encoded Proteins |
cylindromatosis (turban tumor syndrome)
cylindromatosis (turban tumor syndrome)
cylindromatosis (turban tumor syndrome)
|
||||||||||||||||||||||||||||||
Protein Structure | |||||||||||||||||||||||||||||||
Useful resources | Stemformatics EHFPI ImmGen | ||||||||||||||||||||||||||||||
InnateDB Annotation | |||||||||||||||||||||||||||||||
Summary |
Cyld is a deubiquitinase that act as a negative regulator of TLR3 induction in response to LPS. (Demonstrated in human)
Cyld plays a key role in Type I IFN receptor signalling during vesicular stomatitis virus (VSV) infection. In the absence of Cyld, IFN-beta is ineffective in the induction of antiviral genes.
The E3 ligase Itch and deubiquitinase Cyld act together to regulate Tak1 and inflammation.
|
||||||||||||||||||||||||||||||
InnateDB Annotation from Orthologs | |||||||||||||||||||||||||||||||
Summary |
[Homo sapiens] CYLD is a negative regulator of DDX58(RIG-I)-mediated antiviral response by removing Lys 63-linked polyubiquitin chains from RIG-I and TBK1.
[Homo sapiens] CYLD is a crucial negative regulator of innate immune response in Escherichia coli pneumonia.
[Homo sapiens] CYLD is a deubiquitinase that counteracts E3 ligases and therefore play a prominent role in the downregulation of NF-κB signalling and homeostasis.
[Homo sapiens] CYLD is a deubiquitinase that act as a negative regulator of TLR3 induction in response to LPS.
[Homo sapiens] CYLD plays a key role in Type I IFN receptor signalling during vesicular stomatitis virus (VSV) infection. In the absence of CYLD, IFN-beta is ineffective in the induction of antiviral genes. (Demonstrated in mice)
[Homo sapiens] The E3 ligase ITCH and deubiquitinase CYLD act together to regulate TAK1 and inflammation.
[Homo sapiens] MIR362 promotes natural killer-cell function by the down-regulation of CYLD.
|
||||||||||||||||||||||||||||||
Entrez Gene | |||||||||||||||||||||||||||||||
Summary |
This gene encodes a protein that is a member of the ubiquitin C-terminal hydrolase subfamily of the deubiquitinating enzyme family. Members of this family catalyze the removal of ubiquitin from a substrate or another ubiquitin molecule and thereby play important roles in regulating signaling pathways, recycling ubiquitin and regulating protein stability. This protein removes ubiquitin from K-63-linked ubiquitin chains from proteins involved in NF-kappaB signaling and thus acts as a negative regulator of this pathway. In humans mutations in this gene have been associated with cylindromatosis, an autosomal dominant predisposition to tumors of skin appendages. In mouse deficiency of this gene impairs thymocyte development and increases susceptibility to skin and colon tumors. A pseudogene of this gene has been identified on chromosome 1. Alternative splicing results in multiple transcript variants that encode different protein isoforms. [provided by RefSeq, Jan 2013] |
||||||||||||||||||||||||||||||
Gene Information | |||||||||||||||||||||||||||||||
Type | Protein coding | ||||||||||||||||||||||||||||||
Genomic Location | Chromosome 8:88697028-88751945 | ||||||||||||||||||||||||||||||
Strand | Forward strand | ||||||||||||||||||||||||||||||
Band | C3 | ||||||||||||||||||||||||||||||
Transcripts |
|
||||||||||||||||||||||||||||||
Interactions | |||||||||||||||||||||||||||||||
Number of Interactions |
This gene and/or its encoded proteins are associated with 24 experimentally validated interaction(s) in this database.
They are also associated with 46 interaction(s) predicted by orthology.
|
||||||||||||||||||||||||||||||
Gene Ontology | |||||||||||||||||||||||||||||||
Molecular Function |
|
||||||||||||||||||||||||||||||
Biological Process |
|
||||||||||||||||||||||||||||||
Cellular Component |
|
||||||||||||||||||||||||||||||
Orthologs | |||||||||||||||||||||||||||||||
Species
Homo sapiens
Bos taurus
|
Gene ID
Gene Order
Not yet available
|
||||||||||||||||||||||||||||||
Pathways | |||||||||||||||||||||||||||||||
NETPATH | |||||||||||||||||||||||||||||||
REACTOME |
Innate Immune System pathway
Negative regulators of RIG-I/MDA5 signaling pathway
Immune System pathway
NOD1/2 Signaling Pathway pathway
Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways pathway
RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways pathway
|
||||||||||||||||||||||||||||||
KEGG |
RIG-I-like receptor signaling pathway pathway
Osteoclast differentiation pathway
|
||||||||||||||||||||||||||||||
INOH | |||||||||||||||||||||||||||||||
PID NCI | |||||||||||||||||||||||||||||||
Pathway Predictions based on Human Orthology Data | |||||||||||||||||||||||||||||||
NETPATH |
EGFR1 pathway
RANKL pathway
|
||||||||||||||||||||||||||||||
REACTOME |
Negative regulators of RIG-I/MDA5 signaling pathway
RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways pathway
NOD1/2 Signaling Pathway pathway
Innate Immune System pathway
Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways pathway
Immune System pathway
NOD1/2 Signaling Pathway pathway
RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways pathway
Immune System pathway
Negative regulators of RIG-I/MDA5 signaling pathway
Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways pathway
Innate Immune System pathway
|
||||||||||||||||||||||||||||||
KEGG |
RIG-I-like receptor signaling pathway pathway
Osteoclast differentiation pathway
|
||||||||||||||||||||||||||||||
INOH | |||||||||||||||||||||||||||||||
PID NCI |
TNF receptor signaling pathway
Canonical NF-kappaB pathway
|
||||||||||||||||||||||||||||||
Cross-References | |||||||||||||||||||||||||||||||
SwissProt | Q80TQ2 | ||||||||||||||||||||||||||||||
TrEMBL | Q3UY73 | ||||||||||||||||||||||||||||||
UniProt Splice Variant | |||||||||||||||||||||||||||||||
Entrez Gene | 74256 | ||||||||||||||||||||||||||||||
UniGene | Mm.24282 Mm.410103 Mm.490395 | ||||||||||||||||||||||||||||||
RefSeq | NM_001128171 NM_173369 NM_001128169 NM_001128170 XM_006531414 XM_006531415 XM_006531416 XM_006531417 XM_006531418 | ||||||||||||||||||||||||||||||
OMIM | |||||||||||||||||||||||||||||||
CCDS | CCDS22513 CCDS52633 | ||||||||||||||||||||||||||||||
HPRD | |||||||||||||||||||||||||||||||
IMGT | |||||||||||||||||||||||||||||||
MGI ID | MGI:1921506 | ||||||||||||||||||||||||||||||
MGI Symbol | Cyld | ||||||||||||||||||||||||||||||
EMBL | AK039054 AK042764 AK122389 AK134926 BC042438 BC049879 | ||||||||||||||||||||||||||||||
GenPept | AAH42438 AAH49879 BAC30222 BAC31357 BAC65671 BAE22340 | ||||||||||||||||||||||||||||||
RNA Seq Atlas | 74256 | ||||||||||||||||||||||||||||||